StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)

Close on Nov 18, 2026Market cap $8.89MP/E –Yield –

Kazia Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -0.04 AUD. The highest annual figure on record is -0.04 AUD in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Jun 30, 2025-0.04 AUD–
FY2024Jun 30, 2024-0.10 AUD–
FY2023Jun 30, 2023-0.11 AUD–
FY2022Jun 30, 2022-0.19 AUD–
FY2021Jun 30, 2021-0.07 AUD–
FY2020Jun 30, 2020-0.17 AUD–
FY2019Jun 30, 2019-17.86 AUD–
FY2018Jun 30, 2018-12.48 AUD–
FY2017Jun 30, 2017-2.28 AUD–
FY2016Jun 30, 2016-2.82 AUD–

More Kazia Therapeutics figures

See a number that looks wrong?